PharmiWeb.com - Global Pharma News & Resources

Pharmaco - Press Releases

Date Title Company
29-Apr-2025 aap Implantate AG: Postponement of the publication of the annual financial statements and consolidated financial statements for the financial year 2024 aap Implantate AG
29-Apr-2025 Takeda Receives Positive CHMP Opinion for ADCETRIS® (brentuximab vedotin) for the Treatment of Adult Patients with Newly Diagnosed Stage IIb/III/IV Hodgkin Lymphoma in Combination with ECADD Takeda
29-Apr-2025 Mainz Biomed Enters into Technology Partnership with EDX Medical Group Mainz BioMed N.V.
29-Apr-2025 Evotec SE to announce results for the first quarter 2025 on 6 May 2025 Evotec SE
29-Apr-2025 M1 Kliniken AG publishes preliminary figures for the 2024 financial year: Strong EBIT growth (+70%) and significant increase in earnings per share (+57%) M1 Kliniken AG
29-Apr-2025 AEVIS VICTORIA SA (AEVS.SW) – MRH Switzerland's positive momentum continues in the first quarter of 2025, driven by the operational excellence of its flagship establishments AEVIS VICTORIA SA
28-Apr-2025 Secarna Pharmaceuticals adds leading expert to Scientific Advisory Board with appointment of Prof. Dr. Vignali Secarna Pharmaceuticals GmbH & Co. KG
28-Apr-2025 Mainz Biomed Provides First Quarter 2025 Corporate Update and Path to FDA Premarket Approval Mainz BioMed N.V.
28-Apr-2025 BioVersys to Host Virtual KOL Event to Discuss BV100 Phase 2 Ventilator Associated Pneumonia (VABP) Study Against Carbapenem Resistant Acinetobacter on May 7, 2025 BioVersys AG
25-Apr-2025 Pentixapharm to Present First-in-Class Glycan-Dependent CD24 Antibody GT-008 for Solid Tumors at AACR 2025 Pentixapharm Holding AG
25-Apr-2025 Exclusive contract for ViroCAP® My Plasma with Landsberg First Class Aesthetic opens up Viromed's entry into the European cosmetics market Viromed Medical AG
25-Apr-2025 Xlife Sciences AG publishes 2024 Annual Report: Strategic Expansion, Technological Milestones, and International Capital Market Presence Xlife Sciences AG
24-Apr-2025 2024 FULL YEAR RESULTS Affluent Medical reached major new milestones in executing its clinical roadmap Affluent Medical SA
24-Apr-2025 Pentixapharm Signs Contract Manufacturing Agreement for Yttrium-90-based PentixaTher with Eckert & Ziegler SE Pentixapharm Holding AG
24-Apr-2025 Eckert & Ziegler Signs Contract Manufacturing Agreement for Yttrium-90-based PentixaTher with Pentixapharm Eckert & Ziegler SE
24-Apr-2025 Evotec announces significant progress in strategic protein degradation collaboration with Bristol Myers Squibb Evotec SE
24-Apr-2025 Heidelberg Pharma AG: Interim Statement on the First Three Months of Financial Year 2025 Heidelberg Pharma AG
23-Apr-2025 STRATEC REPORTS PRELIMINARY BUSINESS RESULTS FOR 2024, PROVIDES GUIDANCE FOR 2025, AND POSTPONES 2024 ANNUAL REPORT STRATEC SE
23-Apr-2025 Dr. Stephan Rietiker elected as new Chairman of the Board of MetrioPharm AG MetrioPharm
23-Apr-2025 Viromed Medical AG welcomes Dr. Thomas Gutschlag as new Investor Viromed Medical AG